36 related articles for article (PubMed ID: 26400111)
1. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study.
Ahl R; Matthiessen P; Sjölin G; Cao Y; Wallin G; Ljungqvist O; Mohseni S
BMJ Open; 2020 Jul; 10(7):e036164. PubMed ID: 32641361
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?
Samalavicius NE; Dulskas A; Baltruskeviciene E; Smailyte G; Skuciene M; Mikelenaite R; Venslovaite R; Aleknavicius E; Samalavicius A; Lunevicius R
Wideochir Inne Tech Maloinwazyjne; 2016; 11(4):274-282. PubMed ID: 28194248
[TBL] [Abstract][Full Text] [Related]
3. Modeling survival in colon cancer: a methodological review.
Ahmed FE; Vos PW; Holbert D
Mol Cancer; 2007 Feb; 6():15. PubMed ID: 17295918
[TBL] [Abstract][Full Text] [Related]
4. Geriatric prognostic scoring system predicts survival after hepatectomy for elderly patients with liver cancer.
Sakano Y; Noda T; Kobayashi S; Akasaka H; Kato K; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Asaoka T; Shimizu J; Rakugi H; Doki Y; Eguchi H
Ann Gastroenterol Surg; 2024 May; 8(3):498-506. PubMed ID: 38707235
[TBL] [Abstract][Full Text] [Related]
5. Improvement of survival over time for colon cancer patients by anatomical sub-sites.
Kawazuma Y; Tanaka H; Tsukuma H; Ajiki W; Oshima A
Jpn J Cancer Res; 1999 Jul; 90(7):705-10. PubMed ID: 10470281
[TBL] [Abstract][Full Text] [Related]
6. Renal tumour scoring systems: How useful are they?
Kapoor A
Can Urol Assoc J; 2015; 9(1-2):46-7. PubMed ID: 25737755
[No Abstract] [Full Text] [Related]
7. Development and validation of a nomogram to predict which patients with colorectal cancer liver metastases would benefit from primary tumor resection.
He M; Jia Z; Hu L; Wu H
Int J Colorectal Dis; 2023 May; 38(1):144. PubMed ID: 37237238
[TBL] [Abstract][Full Text] [Related]
8. Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.
Fanotto V; Salani F; Vivaldi C; Scartozzi M; Ribero D; Puzzoni M; Montagnani F; Leone F; Vasile E; Bencivenga M; De Manzoni G; Basile D; Fornaro L; Masi G; Aprile G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765854
[TBL] [Abstract][Full Text] [Related]
9. The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis.
Wang J; Li J; Wei S; Xu J; Jiang X; Yang L
Gastroenterol Res Pract; 2021; 2021():9699499. PubMed ID: 34764993
[TBL] [Abstract][Full Text] [Related]
10. Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.
Yang Y; Lu Y; Jiang W; Zhu J; Yan S
World J Surg Oncol; 2020 Aug; 18(1):193. PubMed ID: 32746835
[TBL] [Abstract][Full Text] [Related]
11. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary team intervention associated with improved survival for patients with colorectal adenocarcinoma with liver or lung metastasis.
Chen CH; Hsieh MC; Lao WT; Lin EK; Lu YJ; Wu SY
Am J Cancer Res; 2018; 8(9):1887-1898. PubMed ID: 30323980
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.
Yu Z; Chen Z; Wu J; Li Z; Wu Y
PLoS One; 2017; 12(11):e0188139. PubMed ID: 29141049
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.
S D; L W; B GY; F YH; H SX; Q MZ; Hao C; W CQ; S LZ
World J Surg Oncol; 2017 Jul; 15(1):120. PubMed ID: 28673297
[TBL] [Abstract][Full Text] [Related]
15. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
[No Abstract] [Full Text] [Related]
16. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
17. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
18. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
Gu X; Gao XS; Qin S; Li X; Qi X; Ma M; Yu H; Sun S; Zhou D; Wang W; Xiong W
PLoS One; 2016; 11(9):e0163523. PubMed ID: 27658306
[TBL] [Abstract][Full Text] [Related]
19. Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection.
Li ZM; Peng YF; Du CZ; Gu J
Colorectal Dis; 2016 Mar; 18(3):255-63. PubMed ID: 26400111
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
